Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells

Evaluations of androgen regulated gene (ARG) repertoire provide new insights into the androgen receptor (AR) mediated signaling at the transcriptional level. Definition of ARGs having critical functions in the biology of normal and malignant prostate should aid in identifying new bio-markers and therapeutic targets for prostate cancer (CaP). Using Affymetrix HuGene FL oligonucleotide arrays, temporal expression profiles of ARGs in widely used hormone responsive LNCaP cells, were analysed by hierarchical clustering methods and functional classification. ARGs in response to different androgen concentrations showed temporal co-regulation of genes involved in specific biochemical pathways. This study focuses on our new observations of the coordinated androgen induction of genes (NDRG1, PDIR, HERPUD1, ORP150) involved in the endoplasmic reticulum (ER) stress response pathway. Expression analysis of the two selected ER stress responsive genes, NDRG1 and HERPUD1 in primary CaPs revealed a significantly reduced tumor associated expression. Intriguing linkage of the androgen signaling to ER stress responsive genes, a protective response to protein unfolding or protein damage resulting from cellular stress signals, suggests that androgens may induce such stress signals in CaP cells. Decreased CaP associated expression of two ER stress responsive genes also suggests that possible abrogation of this pathway in prostate tumorigenesis.

[1]  H. Scher,et al.  Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. , 1996, The Journal of clinical endocrinology and metabolism.

[2]  J. Nelson,et al.  Increased fatty acid synthase as a therapeutic target in androgen‐independent prostate cancer progression , 2001, The Prostate.

[3]  M. Litwin,et al.  Identification of an endogenous inhibitor of prostatic carcinoma cell growth , 1995, Nature Medicine.

[4]  C. Graham,et al.  Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells. , 2000, Biochemical and biophysical research communications.

[5]  M. Marahiel,et al.  A superfamily of proteins that contain the cold-shock domain. , 1998, Trends in biochemical sciences.

[6]  J. Cleveland,et al.  A pathway distinct from the mammalian unfolded protein response regulates expression of endoplasmic reticulum chaperones in non‐stressed cells , 1997, The EMBO journal.

[7]  J. Swinnen,et al.  The differentiation‐related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells , 1999, FEBS letters.

[8]  S. Aaronson,et al.  Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. , 1998, Cancer research.

[9]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Schoenberg,et al.  Androgen-receptor gene structure and function in prostate cancer , 2004, World Journal of Urology.

[11]  Jorma Isola,et al.  In vivo amplification of the androgen receptor gene and progression of human prostate cancer , 1995, Nature Genetics.

[12]  S. Narumiya,et al.  Expression: a Novel Approach for Cancer Gene Therapy Prostate-specific Amplification of Expanded Polyglutamine Updated Version Citing Articles E-mail Alerts Prostate-specific Amplification of Expanded Polyglutamine Expression: a Novel Approach for Cancer Gene Therapy1 , 2022 .

[13]  H. Weiss,et al.  Fatty acid synthase: an early molecular marker of progression of prostatic adenocarcinoma to androgen independence. , 2001, The Journal of urology.

[14]  H. E. Fjösne,et al.  Androgen regulation of polyamine synthesis in seminal vesicle and in different lobes of the rat prostate , 1990 .

[15]  J. Swinnen,et al.  Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. , 2001, Molecular endocrinology.

[16]  R. Nitsch,et al.  The Human DIMINUTO/DWARF1 Homolog Seladin-1 Confers Resistance to Alzheimer's Disease-Associated Neurodegeneration and Oxidative Stress , 2000, The Journal of Neuroscience.

[17]  J. Swinnen,et al.  Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. McLaren,et al.  Alpha-difluoromethylornithine and polyamine levels in the human prostate: results of a phase IIa trial. , 2001, Journal of the National Cancer Institute.

[19]  Morris Pollard,et al.  Lobund‐Wistar rat model of prostate cancer in man , 1998, The Prostate.

[20]  Bettuzzi Saverio,et al.  Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens. , 2000 .

[21]  W. Dinjens,et al.  A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[22]  G. Wilding,et al.  Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. , 1997, Journal of the National Cancer Institute.

[23]  D. Tindall,et al.  Defeating prostate cancer: Crucial directions for research—excerpt from the report of the Prostate Cancer Progress Review Group , 1999, The Prostate.

[24]  H. Klocker,et al.  Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor. , 1995, European urology.

[25]  Dyann F. Wirth,et al.  Technical Assessment of the Affymetrix Yeast Expression GeneChip YE6100 Platform in a Heterologous Model of Genes That Confer Resistance to Antimalarial Drugs in Yeast , 2000, Journal of Clinical Microbiology.

[26]  M. Tohyama,et al.  150-kDa Oxygen-regulated Protein (ORP150) Suppresses Hypoxia-induced Apoptotic Cell Death* , 1999, The Journal of Biological Chemistry.

[27]  Toshiyuki Miyata,et al.  Herp, a New Ubiquitin-like Membrane Protein Induced by Endoplasmic Reticulum Stress* , 2000, The Journal of Biological Chemistry.

[28]  G. Buchanan,et al.  Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[30]  F. Claessens,et al.  Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[31]  J W Moul,et al.  A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate. , 2000, Genomics.

[32]  T. Miyata,et al.  Homocysteine-respondent Genes in Vascular Endothelial Cells Identified by Differential Display Analysis , 1996, The Journal of Biological Chemistry.

[33]  T. van Laar,et al.  The novel MMS‐inducible gene Mif1/KIAA0025 is a target of the unfolded protein response pathway , 2000, FEBS letters.

[34]  Andrius Kazlauskas,et al.  Diverse Signaling Pathways Activated by Growth Factor Receptors Induce Broadly Overlapping, Rather Than Independent, Sets of Genes , 1999, Cell.

[35]  D. Tindall,et al.  Androgen receptor signaling in androgen-refractory prostate cancer. , 2001, Journal of the National Cancer Institute.

[36]  D. E. Henson,et al.  Molecular Pathology of Early Cancer , 1999 .

[37]  B. Zetter,et al.  Sensitivity to polyamine-induced growth arrest correlates with antizyme induction in prostate carcinoma cells. , 1999, Cancer research.

[38]  O. Jänne,et al.  Comparison of androgen regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase gene expression in rodent kidney and accessory sex organs. , 1992, Endocrinology.

[39]  M. Vaarala,et al.  Differentially Expressed Genes in Two LNCaP Prostate Cancer Cell Lines Reflecting Changes during Prostate Cancer Progression , 2000, Laboratory Investigation.

[40]  E. Messing,et al.  Low-dose difluoromethylornithine and polyamine levels in human prostate tissue. , 1999, Journal of the National Cancer Institute.

[41]  J. Moul,et al.  Quantitative expression profile of androgen‐regulated genes in prostate cancer cells and identification of prostate‐specific genes , 2001, International journal of cancer.

[42]  A W Partin,et al.  OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate. , 1995, Urology.

[43]  H. Toh,et al.  Molecular Evolution of the Domain Structures of Protein Disulfide Isomerases , 1998, Journal of Molecular Evolution.

[44]  K. Mori.  Tripartite Management of Unfolded Proteins in the Endoplasmic Reticulum , 2000, Cell.

[45]  Peter Walter,et al.  Functional and Genomic Analyses Reveal an Essential Coordination between the Unfolded Protein Response and ER-Associated Degradation , 2000, Cell.